Lincoln Pharmaceuticals Limited (BOM:531633)
India flag India · Delayed Price · Currency is INR
613.45
+82.40 (15.52%)
At close: Feb 12, 2026

Lincoln Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
12,97111,04711,7256,7846,2304,494
Market Cap Growth
-9.55%-5.78%72.84%8.89%38.64%67.94%
Enterprise Value
10,6539,08710,0275,6795,2243,624
Last Close Price
647.60549.78582.16335.85306.89220.85
PE Ratio
14.7713.4212.579.318.987.22
Forward PE
-13.2513.2513.2513.2513.25
PS Ratio
1.961.772.021.331.321.06
PB Ratio
1.811.651.981.351.441.23
P/TBV Ratio
1.811.651.981.351.441.23
P/FCF Ratio
-14.9349.3927.1320.367.43
P/OCF Ratio
-11.8818.5517.288.186.49
PEG Ratio
-0.530.530.530.530.53
EV/Sales Ratio
1.611.461.731.111.110.85
EV/EBITDA Ratio
9.748.8610.026.345.464.16
EV/EBIT Ratio
11.2210.1311.197.055.964.54
EV/FCF Ratio
-12.2842.2322.7117.075.99
Debt / Equity Ratio
0-0.000.000.010.00
Debt / EBITDA Ratio
0.00-0.010.020.020.01
Debt / FCF Ratio
--0.050.080.070.01
Net Debt / Equity Ratio
-0.32-0.29-0.25-0.21-0.26-0.26
Net Debt / EBITDA Ratio
-2.12-1.91-1.51-1.18-1.18-1.08
Net Debt / FCF Ratio
--2.64-6.38-4.24-3.69-1.55
Asset Turnover
-0.830.900.910.961.01
Inventory Turnover
-3.813.853.443.724.29
Quick Ratio
-3.413.413.392.562.74
Current Ratio
-4.714.745.093.904.07
Return on Equity (ROE)
-13.02%17.04%15.59%17.36%18.31%
Return on Assets (ROA)
-7.49%8.70%8.97%11.11%11.85%
Return on Invested Capital (ROIC)
14.96%14.75%16.32%16.32%21.41%21.79%
Return on Capital Employed (ROCE)
-13.00%14.70%15.60%19.80%21.20%
Earnings Yield
6.77%7.45%7.96%10.75%11.13%13.85%
FCF Yield
-6.70%2.02%3.69%4.91%13.47%
Dividend Yield
0.29%0.33%0.31%0.45%0.49%0.68%
Payout Ratio
-4.38%3.22%4.12%4.33%-
Buyback Yield / Dilution
0.01%-----0.15%
Total Shareholder Return
0.35%0.33%0.31%0.45%0.49%0.53%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.